Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Charles River Laboratories International, Inc. (CRL) vs ICON PLC (ICLR)

Charles River Laboratories International, Inc. and ICON PLC are both Diagnostics & Research companies. Charles River Laboratories International, Inc. and ICON PLC are of similar size ($14.1B and $13.4B). Charles River Laboratories International, Inc. has negative trailing earnings, so its P/E is not meaningful; ICON PLC trades at 257×. ICON PLC grew revenue faster over the last twelve months: 3.26% against −0.74%. ICON PLC has the higher net margin (0.51% vs −5.96%) and the higher return on invested capital (1.57% vs 1.07%). Across the 21 metrics below, ICON PLC leads on 17 and Charles River Laboratories International, Inc. on 4.

Valuation

Metric CRL ICLR Diagnostics & Research median
P/E n/m 257.44 33.95
P/S 3.52 1.60 4.87
P/B 4.94 1.41 3.12
Price to free cash flow 37.94 14.98 34.02
EV/EBITDA 29.82 23.55 25.20
EV/Sales 4.12 1.89 5.66
Earnings yield (1.65%) 0.39% (1.75%)
Free cash flow yield 2.64% 6.67% (0.13%)

Profitability

Metric CRL ICLR Diagnostics & Research median
Gross margin 32.67% 23.91% 50.89%
Operating margin 2.25% 3.57% (8.57%)
Net margin (5.96%) 0.51% (6.37%)
Free cash flow margin 9.27% 10.66% 0.00%
Return on equity (7.69%) 0.45% (2.92%)
Return on assets (3.16%) 0.26% (6.71%)
Return on invested capital 1.07% 1.57% 0.00%

Growth

Metric CRL ICLR Diagnostics & Research median
Revenue growth (TTM) (0.74%) 3.26% 7.69%
EPS growth (last fiscal year) (1,555.00%) (69.57%) —
Revenue growth, 5-year CAGR 6.55% 24.15% 7.40%
Net income growth, 5-year CAGR 0.00% (7.15%) 0.00%

Health

Metric CRL ICLR Diagnostics & Research median
Debt to equity 0.92 0.36 0.11
Current ratio 1.35 0.95 2.02
Net debt to EBITDA 3.24 3.34 0.78

Dividend

Metric CRL ICLR Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CRL ICLR Diagnostics & Research median
Market cap 14.09b 13.42b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack